Latest Competition News

Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.

NoviqTech Limited has expanded its sustainability technology footprint through key partnerships in hydrogen and battery recycling, secured a significant grant extension, and announced a $1.25 million capital raise to fuel growth.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

Terragen Holdings reports rapid customer growth for its new dry probiotics, secures a US patent, and posts promising crop trial results, signaling strong momentum in its agricultural biotech offerings.

Weebit Nano reports solid progress in Q4 FY25 with key technology milestones and its first product design license, backed by a strong cash position.

Cobalt Blue Holdings has completed a promising scoping study for its Halls Creek copper-zinc-silver project and secured a key cobalt feedstock contract with Glencore, setting the stage for a final investment decision on its Kwinana Cobalt Refinery by year-end.

RBR Group Limited is strategically positioning itself to capitalise on the restart of major LNG projects in Mozambique, advancing joint ventures and raising capital to meet anticipated demand.

Macro Metals Limited has secured two non-binding letters of intent from licensed Singaporean importers for trial shipments of up to 600,000 cubic meters of sand from its Port Hedland deposit, marking a significant step in its export ambitions.

Blue Energy Limited has been awarded two significant Potential Commercial Areas in Queensland, boosting its contingent gas resources, while facing temporary suspension of pilot wells due to mechanical issues. The company is advancing regulatory approvals and exploring capital raising to support its growth.

Victor Group Holdings delivered a positive net operating cash flow of $586k in the June 2025 quarter, driven by its cloud services and e-learning segments, while maintaining a healthy cash position and no external debt.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Activeport Group Ltd reported a strong Q4 FY25 with significant revenue growth in software and Network as a Service segments, underpinned by new contracts with leading telecom providers and improved cash flow management.